Infuse Asset Management released its Q2 2026 letter detailing current investment strategies and portfolio holdings [1].
The update provides a window into how the firm is navigating the artificial intelligence sector and adjusting its risk exposure across different industries.
In the report, the firm emphasized its commitment to semiconductor leaders. David Miller, Managing Director at Infuse Asset Management, said, "We believe that NVIDIA remains a key beneficiary of the ongoing AI revolution" [2]. This stance suggests the firm views the current AI infrastructure build-out as a sustainable growth driver for the company.
However, the firm is not maintaining all positions. A report from Seeking Alpha said that Infuse Asset Management is looking to trim Axon Enterprise (AXON) from its portfolio [3]. The reduction in Axon holdings indicates a shift in the firm's valuation or outlook regarding the public safety technology provider.
Separate from the Infuse strategy, broader market trends show significant movement in asset management. Ninety One reported a jump in assets under management to £152 billion [4]. This increase in AUM coincided with a rise in the company's share price [4].
Infuse Asset Management uses these quarterly letters to communicate specific strategic shifts to its investors. By balancing high-growth tech assets like NVIDIA with the trimming of other holdings, the firm aims to optimize its portfolio for the remainder of the year [1].
“"We believe that NVIDIA remains a key beneficiary of the ongoing AI revolution,"”
The strategic shift by Infuse Asset Management reflects a concentrated bet on AI hardware infrastructure over other tech sectors. By trimming Axon Enterprise while holding NVIDIA, the firm is prioritizing the foundational components of the AI revolution over diversified technology services, signaling a high-conviction approach to market volatility in 2026.
